Mechanisms by which docosahexaenoic acid and related fatty acids reduce colon cancer risk and inflammatory disorders of the intestine
about
Polyunsaturated fatty acid metabolism in prostate cancerOmega-3 Polyunsaturated Fatty Acids: The Way Forward in Times of Mixed EvidenceChemoprotective epigenetic mechanisms in a colorectal cancer model: Modulation by n-3 PUFA in combination with fermentable fiberProteomic approaches to predict bioavailability of fatty acids and their influence on cancer and chronic disease prevention.Membrane raft organization is more sensitive to disruption by (n-3) PUFA than nonraft organization in EL4 and B cells.Detecting Multivariate Gene Interactions in RNA-Seq Data Using Optimal Bayesian Classification.Incorporation of a dietary omega 3 fatty acid impairs murine macrophage responses to Mycobacterium tuberculosis.Interaction of dietary fatty acids with tumour necrosis factor family cytokines during colon inflammation and cancer.Key roles for GRB2-associated-binding protein 1, phosphatidylinositol-3-kinase, cyclooxygenase 2, prostaglandin E2 and transforming growth factor alpha in linoleic acid-induced upregulation of lung and breast cancer cell growth.Imaging inflammation in mouse colon using a rapid stage-scanning confocal fluorescence microscope.Maintenance of remission in inflammatory bowel disease using omega-3 fatty acids (fish oil): a systematic review and meta-analyses.Weight Loss via exercise with controlled dietary intake may affect phospholipid profile for cancer prevention in murine skin tissuesThe microbiome and colorectal neoplasia: environmental modifiers of dysbiosisn-3 Fatty acids uniquely affect anti-microbial resistance and immune cell plasma membrane organizationThe Enigmatic Gut in Cystic Fibrosis: Linking Inflammation, Dysbiosis, and the Increased Risk of Malignancy.Tumor growth reduction is regulated at the gene level in Walker 256 tumor-bearing rats supplemented with fish oil rich in EPA and DHA.Antineoplastic effects of n-3 polyunsaturated fatty acids in combination with drugs and radiotherapy: preventive and therapeutic strategies.The Interaction between Dietary Fiber and Fat and Risk of Colorectal Cancer in the Women's Health Initiative.Role of plasma membrane lipid composition on cellular homeostasis: learning from cell line models expressing fatty acid desaturases.n-3 Polyunsaturated fatty acids exert immunomodulatory effects on lymphocytes by targeting plasma membrane molecular organization.Tetradecylthioacetic acid inhibits proliferation of human SW620 colon cancer cells--gene expression profiling implies endoplasmic reticulum stress.The Role of Aspirin, Vitamin D, Exercise, Diet, Statins, and Metformin in the Prevention and Treatment of Colorectal Cancer.Docosahexaenoic Acid Induces Growth Suppression on Epithelial Ovarian Cancer Cells More Effectively than Eicosapentaenoic Acid.Elimination of ALDH+ breast tumor initiating cells by docosahexanoic acid and/or gamma tocotrienol through SHP-1 inhibition of Stat3 signaling.A combination of eicosapentaenoic acid-free fatty acid, epigallocatechin-3-gallate and proanthocyanidins has a strong effect on mTOR signaling in colorectal cancer cells.Effects of polyunsaturated fatty acids on the growth of gastric cancer cells in vitro.Emerging role of chemoprotective agents in the dynamic shaping of plasma membrane organization.Distinct roles of different forms of vitamin E in DHA-induced apoptosis in triple-negative breast cancer cells.Human serum-derived hydroxy long-chain fatty acids exhibit anti-inflammatory and anti-proliferative activity.Colorectal cancer cell growth inhibition by linoleic acid is related to fatty acid composition changes.Linoleic acid suppresses colorectal cancer cell growth by inducing oxidant stress and mitochondrial dysfunctionAnticancer effects of an extract from the scallop Patinopecten yessoensis on MCF-7 human breast carcinoma cells.The influence of EPA and DHA on markers of inflammation in 3T3-L1 cells at different stages of cellular maturation.Highly purified eicosapentaenoic acid as free fatty acids strongly suppresses polyps in Apc(Min/+) mice.n-3 PUFA improves fatty acid composition, prevents palmitate-induced apoptosis, and differentially modifies B cell cytokine secretion in vitro and ex vivo.Identification of the Eph receptor pathway as a novel target for eicosapentaenoic acid (EPA) modification of gene expression in human colon adenocarcinoma cells (HT-29).Interactive effects of fatty acid and butyrate-induced mitochondrial Ca²⁺ loading and apoptosis in colonocytes.Growth condition optimization for docosahexaenoic acid (DHA) production by Moritella marina MP-1.Dietary fatty acids specifically modulate phospholipid pattern in colon cells with distinct differentiation capacities.Olive oil and omega-3 polyunsaturated fatty acids suppress intestinal polyp growth by modulating the apoptotic process in ApcMin/+ mice.
P2860
Q24629893-BB56D316-C2BB-4DE5-9FD7-79244FAB46D6Q26798057-B3D0521C-9948-43E0-98C5-EEFC3129F34AQ28392829-83508FED-FA18-441F-871B-423E4C74F35EQ30417403-3471B58D-A7FE-4C6F-A1CA-2608F7F6A429Q30500247-A1800D92-C4C9-4099-8AEC-AB90F87731D0Q31002117-9C90EF5E-C4D6-4D35-B593-044A331A3B7AQ33595824-04870E7D-3F2E-442B-A45D-F34E3D9F529AQ33614335-C2CADD05-D7AF-4471-806D-93DAB3BB9565Q34069510-2219B423-BC24-4BA4-891F-F3355423A1A8Q34165335-B38DE1D6-C83D-49CC-8E94-8D6CB18E0687Q34620794-02B428BD-7824-4A1F-8E2B-B9080B0F5846Q34845647-D6D7AAF9-61EF-448E-BC26-7D96CAD0580FQ34944458-79AE20C6-13FC-4436-97B6-A502924B2359Q35243727-B2BA276F-2BAA-4D59-927D-0D5F4AD3A3A6Q36268539-19DFB1A0-091D-484D-8DA8-780406640C73Q37371498-05729B3A-1907-4740-AD25-BA1D9C58BEB1Q37448363-CF502A36-C774-41E5-BDD6-E36A2F792222Q37535400-95B29F8F-44BB-485D-974F-3FB8F4D9F2A4Q37668363-C7EBE9D2-161F-4BDC-84A5-68F8D07D9EE8Q37948573-DACF308B-7B22-45B3-9F02-F3E0DEACA6DFQ38330840-D8B16A48-A749-4447-978A-96ABDE86E0F5Q38549743-11523B97-17E0-4C22-A6C4-F94FDB9A7AF8Q38788974-4ECEAF3F-86AD-4CA9-8747-7DAEDB6F4EF3Q38913330-113767B9-442F-4107-A17B-0CAF0684F014Q38966079-58CB49ED-E416-4A0F-A6BB-432632940F0AQ39153723-CAC86B6D-4020-4952-AB6A-153A475ABB6BQ39200406-981885B2-40AC-4627-AD8F-143A1E93497AQ39329673-4B092AE6-2A89-41DA-88D0-79BF4F2E7213Q39541011-F43D380E-D1AD-45B8-B427-B9152C3FAF96Q39625393-43721562-05A8-4DDE-A3B7-4216E8B5B45BQ39651901-EC4EA01E-F169-42B9-A9CD-905BAB4C6FE6Q41144514-86802D13-4BBD-4258-9919-B3BB201B6E53Q41768999-B5F745A5-4DE9-4D5A-A568-EDB35D6CAFDAQ41954579-BBC65AE4-07AE-47AE-A5FA-6D70E7D34A74Q42592006-16697EF5-8790-41FA-BFA6-B621E037205BQ42633983-1A8AECEA-82AC-4730-8B04-EAB2BE1A7D67Q42869244-ECA82E81-6A07-43D2-AA9B-0067F8593C75Q45221311-67ADC54F-3EE7-4183-9202-4A9256D96499Q46578950-4994F2E2-ECB7-45D4-A8B6-5EBEF87B1224Q53240790-0F71B7C0-3083-43F0-BB87-76C6A5690B4F
P2860
Mechanisms by which docosahexaenoic acid and related fatty acids reduce colon cancer risk and inflammatory disorders of the intestine
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mechanisms by which docosahexa ...... ory disorders of the intestine
@en
Mechanisms by which docosahexa ...... ry disorders of the intestine.
@nl
type
label
Mechanisms by which docosahexa ...... ory disorders of the intestine
@en
Mechanisms by which docosahexa ...... ry disorders of the intestine.
@nl
prefLabel
Mechanisms by which docosahexa ...... ory disorders of the intestine
@en
Mechanisms by which docosahexa ...... ry disorders of the intestine.
@nl
P2093
P2860
P1476
Mechanisms by which docosahexa ...... ory disorders of the intestine
@en
P2093
David N McMurray
Jeongmin Seo
Joanne R Lupton
Robert S Chapkin
P2860
P356
10.1016/J.CHEMPHYSLIP.2008.02.011
P577
2008-03-04T00:00:00Z